SHANGHAI, China, Jan. 15, 2023 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of ...
Clover Biopharmaceuticals and Dynavax Technologies Corporation (NASDAQ: DVAX) have executed the commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant for use in Clover's protein-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results